Regulatory Exclusivity: PATENT CHALLENGE
✉ Email this page to a colleague
Drugs with Patent Challenge Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | TOPIRAMATE | topiramate | 217795 | Oct 31, 2024 | RX | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | PATENT CHALLENGE |
| Baxter Hlthcare Corp | ACETAMINOPHEN | acetaminophen | 214331 | May 21, 2025 | RX | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | PATENT CHALLENGE |
| Natco Pharma Ltd | BOSENTAN | bosentan | 213154 | Feb 5, 2025 | RX | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | PATENT CHALLENGE |
| >Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |
